Research Paper Volume 15, Issue 16 pp 8471—8486

Tumor-derived exosomes RNA expression profiling identifies the prognosis, immune characteristics, and treatment in HR+/HER2-breast cancer

class="figure-viewer-img"

Figure 5. The ES predicting the sensitivity to chemosensitivity and endocrine therapy. Scatter plots for associations between drug sensitivity values (IC50) and (A) vincristine, (B) paclitaxel.